Bilcare EBITDA jumped on 22.6% while Revenue decreased on 4.8%
30-05-2016 • About Bilcare (
$BI) • By InTwits
Bilcare reported FY2016 financial results today. Below you can find a comprehensive analysis of the key data driving the company's performance and the stock price.
Revenue and profitability
Bilcare's Revenue decreased on 4.8%. During FY2012-FY2016 Revenue growth bottomed in FY2014 at -13.7% and was accelerating since that time. Despite revenue decline the EBITDA margin expanded. EBITDA Margin increased on 2.4 pp from 8.2% to 10.6% in FY2016.
Net Income margin increased slightly on 1.6 pp from -8.0% to -6.4% in FY2016. Net Income margin declined at -2.9 pp per annum in the last 5 years.
Financial and operational results
Bilcare ($BI) key annual financial indicators| mln. INR | 2012 | 2013 | 2014 | 2015 | 2016 | 2016/2015 |
|---|
P&L
|
|---|
| Revenue | 36,418 | 35,467 | 30,620 | 26,923 | 25,634 | -4.8% |
| EBITDA | 5,452 | 3,874 | 4,252 | 2,218 | 2,718 | 22.6% |
| Net Income | 1,366 | 396 | -1,133 | -2,160 | -1,637 | |
Balance Sheet
|
|---|
| Cash | 1,725 | 944 | 1,060 | 1,563 | | |
| Short Term Debt | 673 | 2,244 | 2,642 | 2,482 | | |
| Long Term Debt | 13,032 | 18,651 | 18,817 | 20,632 | | |
Cash flow
|
|---|
| Capex | 3,990 | 10,343 | 4,718 | 0 | | |
Ratios
|
|---|
| Revenue growth | 59.3% | -2.6% | -13.7% | -12.1% | -4.8% | |
| EBITDA growth | -53.4% | -28.9% | 9.8% | -47.8% | 22.6% | |
|
|---|
| EBITDA Margin | 15.0% | 10.9% | 13.9% | 8.2% | 10.6% | 2.4% |
| Net Income Margin | 3.7% | 1.1% | -3.7% | -8.0% | -6.4% | 1.6% |
| CAPEX, % of revenue | 11.0% | 29.2% | 15.4% | 0.0% | | |
|
|---|
| ROIC | 12.8% | 7.3% | 2.8% | 0.9% | | |
| ROE | 11.4% | 3.0% | -8.6% | -17.9% | | |
| Net Debt/EBITDA | 2.2x | 5.2x | 4.8x | 9.7x | 0.0x |
Peers in Healthcare Supplies
Below you can find Bilcare benchmarking vs. other companies in Healthcare Supplies industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.
Top companies by Revenue growth, %
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Gujarat Meditech ($GUJMEDI) | -99.3% | 7.0% | -61.6% | -43.4% | - |
| |
|---|
| Median (1 company) | -99.3% | 7.0% | -61.6% | -43.4% | - |
|---|
| Bilcare ($BI) | - | -2.6% | -13.7% | -12.1% | -4.8% |
Top companies by EBITDA margin, %
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Gujarat Meditech ($GUJMEDI) | 15.1% | 0.7% | -9.8% | 7.2% | - |
| |
|---|
| Median (1 company) | 15.1% | 0.7% | -9.8% | 7.2% | - |
|---|
| Bilcare ($BI) | 15.0% | 10.9% | 13.9% | 8.2% | 10.6% |
Top companies by ROIC, %
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Gujarat Meditech ($GUJMEDI) | - | - | - | - | - |
| |
|---|
| Median (1 company) | - | - | - | - | - |
|---|
| Bilcare ($BI) | 12.8% | 7.3% | 2.8% | 0.9% | - |
Top companies by Net Debt / EBITDA
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Gujarat Meditech ($GUJMEDI) | 0.0x | 0.0x | - | 0.0x | - |
| |
|---|
| Median (1 company) | 0.0x | 0.0x | - | 0.0x | - |
|---|
| Bilcare ($BI) | 2.2x | 5.2x | 4.8x | 9.7x | 0.0x |
